期刊文献+

NQO1与乳腺癌研究进展 被引量:5

Research progresses of NQO1 in breast cancer
原文传递
导出
摘要 目的:总结了醌氧化还原酶〔NAD(P)H:quinone oxidoreductase 1,NQO1〕在乳腺癌的发生发展中可能起到的作用及其与乳腺癌防治的联系。方法:应用PubMed、Springer Link及CNKI期刊全文数据库检索系统,以"乳腺癌(breast cancer)、NQO1、单核苷酸多态性(SNP)、雌激素(estrogen)"等为关键词,检索2000-2012年的相关文献,共检索到英文文献93篇,中文文献2篇。纳入标准:1)NQO1的生物学特征;2)NQO1的基因定位及其多态性;3)NQO1在乳腺癌中发生发展的作用及其表达;4)NQO1与乳腺癌的治疗及预后。符合分析的文献28篇。结果:NQO1作为人体内一种可被多种物质诱导的还原酶,在很多癌组织中表达异常,它具有多种功能,包括对苯醌等醌类物质产生的细胞毒性的解毒、氧化应激状态下稳定p53蛋白的表达、防止雌激素及其代谢产物对人类细胞的毒性和致癌作用等。NQO1频繁的基因多态性导致了个体中此酶活性的降低或缺乏,可能增加了乳腺癌的易感性。结论:NQO1对雌激素的作用使其在雌激素依赖性恶性肿瘤乳腺癌的发病及防治中有着重要意义,是一个强大的预后预测指标。 OBJECTIVE: To summarize the recent progress of NAD(P)H, quinone oxidoreductase 1 (NQO1) in de- velopment and prevention of breast cancer. METHODS: Related papers were searched with "breast cancer, NQO1, SNP, estrogen" as key words between 2000 and 2012 in PubMed, Springer Link and CNKI. Totally 93 English papers and 2 Chinese papers were obtained. A total of 28 papers were selected according to the standard as follows: Biological char- acteristics of NQO1. Assignment of NQO1 and its polymorphism. Function of NQO1 in development of breast cancer and its expression. Relation between NQO1 and the treatment and prognosis of breast cancer. RESULTS: NQO1 is a reduc- tase in human cells which can be induced by a variety of substances, it is expressed in multiped cancer tissues abnormally. It has various functions including the detoxification of quinone cytotoxicity, stable expression of p53 protein, prevention of the toxicity and carcinogenesis of estrogen and its metabolites to human cells. The polymorphism of NQO1 gene fre- quently leads to reduction even lack of this enzyme activity in the individual, thus it may increase the risk of breast cancer. CONCLUSIONS: As breast cancer is an estrogen-dependent cancer, NQO1 plays an important role in its pathogenesis, prevention and treatment by affecting estrogen. Consequently NQOI is a powerful prognostic indicator.
出处 《中华肿瘤防治杂志》 CAS 北大核心 2014年第8期641-644,共4页 Chinese Journal of Cancer Prevention and Treatment
基金 桂林市科学研究与技术开发计划(20110119-1-9)
关键词 依赖还原型辅酶Ⅰ Ⅱ醌氧化还原酶l 乳腺肿瘤 单核苷酸多态性 雌激素 综述文献 NAD(P) H: quinone oxidoreductase 1 breast neoplasms single-nucleotide polymorphisms estrogen review literature
  • 相关文献

参考文献28

  • 1Ross D, Kepa JK, Winski SL, et al. NAD(P)H:quinone oxi-doreductase 1 (NQ01): chemoprotection, bioactivation , gene regulation and genetic polymorphisms [J]. Chern Bioi Interact, 2000,129(122):77297. 被引量:1
  • 2Cleton-]ansen AM, van Eijk R, Lombaerts M, et al. ATBF1 and NQ01 as candidate targets for allelic loss at chromosome arm 16q in breast cancer: Absence of somatic ATBF1 mutations and no role for the C609T NQ01 polymorphism[J]. BMC Cane-er,2008,8:105. 被引量:1
  • 3Fryatt T, Pettersson HI, Gardipee WT, et al. Novel quinoline quinone antitumor agents: structure metabolism studies with NAD (P) H: quinone oxidoreductase (NQO1) [J]. Bioorg Med Chem. 2004.12(7) :1667-1687. 被引量:1
  • 4Tsai CW. Lin CY. Wang YJ. Carnosic acid induces the NAD (P) H: quinone oxidoreductase 1 expression in rat clone 9 cells through the p38/nuclear factor erythroid-2 related factor 2 path-way[J]. J Nutr.2011. 141(12): 2119-2125. 被引量:1
  • 5Rollinson SvRoddam P.Kane E.et al. Polymorphism variation within the glutathione S-transferase gene and ridk of adult leukemia[J]. Carcinogenesis. 2000. 21( 1) : 43-47. 被引量:1
  • 6Luch A. Nature and nurture-lessons from chemical carcinogene-sis[J]. Nat Rev Cancer. 2005.5(2) :113-125. 被引量:1
  • 7Burchiel SW. Thompson T A. Lauer FT. et al. Activation of dioxin response element (DRE)-associated genes by benzo(a) py-rene 3. 6-quinone and benzot a) pyrene 1, 6-quinone in MCF-10A human mammary epithelial cells[J]. Toxicol Appl Pharmacol , 2007.221(2):203-214. 被引量:1
  • 8Vasiliou V. Ross D. Nebert DW. Update of the NAD(P)H:qui-none oxidoreductase (NQOl) gene family[J]. Hum Genomics , 2006.2(5) :329-335. 被引量:1
  • 9Larson RA, Wang Y. Banerjee M. et al. Prevalence of the inac-tivating 609C->T polymorphism in the NAD(P)H:quinone ox-idoreductase (NQO1) gene in patients with primary and therapy-related myeloid leukemia[J]. Blood.1999.94(2) :803-807. 被引量:1
  • 10Knappskog S. Lanning PE. P53 and its molecular basis to che-moresistance in breast cancer ] L]. Expert Opin Ther Targets. 2012.16 Suppl1 :23-30. 被引量:1

同被引文献66

  • 1陈晓艺,张白凌,陈少杰.组织蛋白酶D与基质金属蛋白酶-9在口腔鳞癌的表达[J].福建医科大学学报,2006,40(6):560-562. 被引量:8
  • 2邢洁,李鹏,张澍田.中国结直肠癌防治现状[J].中华结直肠疾病电子杂志,2013,2(6):288-291. 被引量:14
  • 3周志伟,万德森,王国强,潘志忠,卢汉平,高锦辉,丁培荣.结直肠癌雌激素受体及孕激素受体的定量研究[J].癌症,2004,23(7):851-854. 被引量:12
  • 4白建华,裴素霞,陈兆平,丁玉喜,路泽华,马云飞.大肠癌组织中p53蛋白和基因的表达及意义[J].中华肿瘤防治杂志,2007,14(8):607-609. 被引量:3
  • 5Fan L, Strasser-Weippl K, Li J J, et al. Breast cancer in China [J]. Lancet Oncol, 2014,15(7) :e279 -89. 被引量:1
  • 6Goldhirsch A, Wood W C, Coates A S, et al. Strategies for sub- types-dealing with the diversity of breast cancer: highlights of the St. Gallen international expert consensus on the primary therapy ofearly breast cancer 2011 [ J ]. Ann Oncol, 2011,22 (8) : 1736 - 47. 被引量:1
  • 7Cheang M C, Chia S K, Voduc D, et al. Ki-67 index, HER2 sta- tus, and prognosis of patients with Luminal B breast cancer[ J]. J Natl Cancer Inst, 2009,101 (10) :736 - 50. 被引量:1
  • 8van Minekwitz G, Untch M, Blohmer J U, et al. Definition and impact of pathologic complete response on prognosis after neoadju- rant chemotherapy in various intrinsic breast cancer subtypesE J]. J Clin Oncol, 2012,30 ( 15 ) : 1796 - 804. 被引量:1
  • 9Chen X S, Wu J Y, Huang O, et al. Molecular subtype can pre- dict the response and outcome of chinese locally advanced breast cancer patients treated with preoperative therapy[ J ]. Oncol Rep, 2010,23(5) :1213 -20. 2014,30(1) :10 -4. 被引量:1
  • 10Widodo I, Dwianingsih E K, Triningsih E, et al. Clinicopatholog- ieal features of indonesian breast cancers with different molecular subtypes[J]. Asian Pae J Cancer Prey, 2014,15 ( 15 ) :6109 - 13. 被引量:1

引证文献5

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部